Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Change in Inventory (2021 - 2025)

Historic Change in Inventory for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to -$6.8 million.

  • Kiniksa Pharmaceuticals International's Change in Inventory fell 982.52% to -$6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.7 million, marking a year-over-year increase of 31059.09%. This contributed to the annual value of -$4.8 million for FY2024, which is 14996.32% down from last year.
  • According to the latest figures from Q3 2025, Kiniksa Pharmaceuticals International's Change in Inventory is -$6.8 million, which was down 982.52% from $26.1 million recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Change in Inventory registered a high of $26.1 million during Q2 2025, and its lowest value of -$6.8 million during Q3 2025.
  • In the last 5 years, Kiniksa Pharmaceuticals International's Change in Inventory had a median value of $533000.0 in 2023 and averaged $2.1 million.
  • As far as peak fluctuations go, Kiniksa Pharmaceuticals International's Change in Inventory tumbled by 58322.58% in 2022, and later surged by 132213.88% in 2024.
  • Kiniksa Pharmaceuticals International's Change in Inventory (Quarter) stood at -$1.9 million in 2021, then surged by 461.37% to $7.0 million in 2022, then decreased by 20.62% to $5.5 million in 2023, then tumbled by 141.81% to -$2.3 million in 2024, then crashed by 192.96% to -$6.8 million in 2025.
  • Its Change in Inventory stands at -$6.8 million for Q3 2025, versus $26.1 million for Q2 2025 and -$4.3 million for Q1 2025.